Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Treatment for metastatic testicular cancer has generally met greatest success when it has involved platinum-based chemotherapy and this is widely used for metastatic disease in most centers. However, surgical techniques should not be excluded. Retroperitoneal lymph node dissection has enabled a high cure rate to be achieved when used in conjunction with chemotherapy in patients with more advanced stage cancers.

Original publication

DOI

10.1586/14737140.5.1.109

Type

Journal article

Journal

Expert Rev Anticancer Ther

Publication Date

02/2005

Volume

5

Pages

109 - 112

Keywords

Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Humans, Lymph Node Excision, Male, Neoplasm Metastasis, Prognosis, Survival, Testicular Neoplasms